375 related articles for article (PubMed ID: 26190563)
1. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.
Dobloug GC; Garen T; Brunborg C; Gran JT; Molberg Ø
Semin Arthritis Rheum; 2015 Dec; 45(3):301-8. PubMed ID: 26190563
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort.
Dobloug C; Garen T; Bitter H; Stjärne J; Stenseth G; Grøvle L; Sem M; Gran JT; Molberg Ø
Ann Rheum Dis; 2015 Aug; 74(8):1551-6. PubMed ID: 24695011
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of idiopathic inflammatory myopathies in South Africa.
Chinniah KJ; Mody GM
Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
[TBL] [Abstract][Full Text] [Related]
4. Cancer Risk and Mortality in Hospitalized Patients With Idiopathic Inflammatory Myopathies in Western Australia.
Nossent JC; Keen H; Preen D; Inderjeeth C
J Rheumatol; 2024 Apr; 51(4):396-402. PubMed ID: 38302176
[TBL] [Abstract][Full Text] [Related]
5. [Clinical course of idiopathic inflammatory myopathies: complications, survival and prognostic factors].
Miró O; Laguno M; Alonso JR; Casademont J; Herrero C; Selva A; Urbano-Márquez A; Grau JM
Med Clin (Barc); 1999 Apr; 112(14):521-6. PubMed ID: 10363237
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus.
Limaye VS; Lester S; Blumbergs P; Roberts-Thomson PJ
Int J Rheum Dis; 2010 May; 13(2):132-7. PubMed ID: 20536597
[TBL] [Abstract][Full Text] [Related]
7. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan.
Yamasaki Y; Yamada H; Ohkubo M; Yamasaki M; Azuma K; Ogawa H; Mizushima M; Ozaki S
J Rheumatol; 2011 Aug; 38(8):1636-43. PubMed ID: 21572147
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study.
Cho SK; Kim H; Myung J; Nam E; Jung SY; Jang EJ; Yoo DH; Sung YK
J Korean Med Sci; 2019 Mar; 34(8):e55. PubMed ID: 30833879
[TBL] [Abstract][Full Text] [Related]
9. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
[TBL] [Abstract][Full Text] [Related]
10. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study.
Huang YL; Chen YJ; Lin MW; Wu CY; Liu PC; Chen TJ; Chen YC; Jih JS; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Br J Dermatol; 2009 Oct; 161(4):854-60. PubMed ID: 19558555
[TBL] [Abstract][Full Text] [Related]
11. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.
Chen YJ; Wu CY; Huang YL; Wang CB; Shen JL; Chang YT
Arthritis Res Ther; 2010; 12(2):R70. PubMed ID: 20398365
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic inflammatory myopathies.
van der Kooi AJ; de Visser M
Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315
[TBL] [Abstract][Full Text] [Related]
13. Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases.
Tan JA; Roberts-Thomson PJ; Blumbergs P; Hakendorf P; Cox SR; Limaye V
Int J Rheum Dis; 2013 Jun; 16(3):331-8. PubMed ID: 23981756
[TBL] [Abstract][Full Text] [Related]
14. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study.
Kuo CF; See LC; Yu KH; Chou IJ; Chang HC; Chiou MJ; Luo SF
Br J Dermatol; 2011 Dec; 165(6):1273-9. PubMed ID: 21895620
[TBL] [Abstract][Full Text] [Related]
15. Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients.
Sun C; Tian X; Yang H; Yang H; Li S; Jiang W; Peng Q; Wang G; Lu X
Clin Exp Rheumatol; 2024 Feb; 42(2):302-308. PubMed ID: 38488095
[TBL] [Abstract][Full Text] [Related]
16. [Survival analysis and risk factors for survival in idiopathic inflammatory myopathies: a retrospective cohort study].
Yin G; Liang Y; Deng R; Wang Y; Xie QB; Zuo C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):818-22. PubMed ID: 24325120
[TBL] [Abstract][Full Text] [Related]
17. The geoepidemiology of autoimmune muscle disease.
Prieto S; Grau JM
Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
[TBL] [Abstract][Full Text] [Related]
18. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
Bai Z; Shen G; Dong L
Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic inflammatory myopathy: clinicopathological observations in the Indian population.
Prasad ML; Sarkar C; Roy S; Bagchi U; Singh RR; Singh YN; Sharma S; Malaviya AN
Br J Rheumatol; 1992 Dec; 31(12):835-9. PubMed ID: 1458290
[TBL] [Abstract][Full Text] [Related]
20. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
